Results 221 to 230 of about 2,215,182 (398)
Correction: Impact of difficult-to-treat depression for patients and society: a real-world study. [PDF]
Benavente S +7 more
europepmc +1 more source
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang +7 more
wiley +1 more source
Correction: Neuroimaging markers of aberrant brain activity and treatment response in schizophrenia patients based on brain complexity. [PDF]
Liu L +8 more
europepmc +1 more source
Transcranial Magnetic stimulation in Psychiatry: Past, Current and Future
Burak Yuluğ, Ahmet Aslan
openalex +2 more sources
This study demonstrates meningeal lymphatic impairment associated with lung adenocarcinoma brain metastasis progression in both human patients and mouse models, establishes clinically applicable non‐invasive imaging biomarkers for quantitative analyzing mLV structure and function, and reveals mLVs as robust prognostic indicators and promising potential
Yuan Zhang +15 more
wiley +1 more source
A Further Leap From the Current Status of the <i>Journal of the Korean Academy of Child and Adolescent Psychiatry</i> (<i>JKACAP</i>). [PDF]
Son JW.
europepmc +1 more source
Australian and New Zealand Psychiatry and the World Psychiatric Association [PDF]
Helen Herrman
openalex +1 more source
Molecularly imprinted polymeric nanocarriers (nanoMIPs) offer robust, antibody‐mimetic platforms to overcome the blood‐brain barrier. The article surveys nanoMIP design and ligand‐directed surface engineering that harness receptor‐mediated transcytosis, and highlights therapeutic and diagnostic applications in neurodegeneration, brain tumors and ...
Ranjit De, Shuliang Shi, Kyong‐Tai Kim
wiley +1 more source

